drugset / Trial / NCT02623881

Cervical Pessary vs. Vaginal Progesterone for Preventing Premature Birth in IVF Twin Pregnancies

NCT02623881

RandomizedParallel-groupOpen-labelTreatment

Summary

To compare the effectiveness of cervical pessary (Arabin) and vaginal progesterone for preventing premature birth in twin pregnancies after IVF

Timeline

Start
2016-03-04
Primary completion
2017-11-02
Completion
2017-11-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Progesterone Other / unclassified 400 mg Intravenous

Indications